The Filings Report

Amphenol Corporation

APHNYSECIK 820313Technology / Electronic Components & Instrumentsfiscal year ends December73 quarters since 2008

Revenue, Q2 FY2026
$8.8B
+55.0% on Q2 FY2025
Net income
$1.8B
+62.1% on Q2 FY2025
Free cash flow
$1.2B
+7.3% on Q2 FY2025
Diluted EPS
$1.37
+59.3% on Q2 FY2025
Revenue, TTM
$29.0B
trailing four quarters
Net margin, TTM
17.7%
net income $5.1B
Free cash flow, TTM
$4.7B
$5.9B less $1.2B capex
Cash and equivalents
$4.7B
long-term debt —, Jun 30, 2026
Shares, 12-month change
+1.0%
1.23B shares, Jun 30, 2026
Buybacks, TTM
$710M
0.7% of market value
Dividends, TTM
$1.0B
1.0% of market value
Market value
$97.8B
at the close, buybacks

Latest quarter Q2 FY2026, filed July 31, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q2 FY2026, the quarter ended June 30, 2026, Amphenol Corporation reported revenue of $8.8B, +55.0% on Q2 FY2025, and net income of $1.8B (+62.1%). Operating margin was 29.5%. Free cash flow, operating cash flow less capital expenditures, was $1.2B ($1.6B less $356M). Diluted earnings per share were $1.37.

The last 16 quarters

Q3 FY2022 to Q2 FY2026, through the filing of July 31, 2026.

Revenue and net incomeRevenueNet income
$0$3B$5B$8B$10BQ3'22, Revenue: $3.3BQ3'22, Net income: $497MQ3'22Q4'22, Revenue: $3.2BQ4'22, Net income: $508MQ4'22Q1'23, Revenue: $3.0BQ1'23, Net income: $439MQ1'23Q2'23, Revenue: $3.1BQ2'23, Net income: $461MQ2'23Q3'23, Revenue: $3.2BQ3'23, Net income: $514MQ3'23Q4'23, Revenue: $3.3BQ4'23, Net income: $514MQ4'23Q1'24, Revenue: $3.3BQ1'24, Net income: $549MQ1'24Q2'24, Revenue: $3.6BQ2'24, Net income: $525MQ2'24Q3'24, Revenue: $4.0BQ3'24, Net income: $604MQ3'24Q4'24, Revenue: $4.3BQ4'24, Net income: $746MQ4'24Q1'25, Revenue: $4.8BQ1'25, Net income: $738MQ1'25Q2'25, Revenue: $5.7BQ2'25, Net income: $1.1BQ2'25Q3'25, Revenue: $6.2BQ3'25, Net income: $1.2BQ3'25Q4'25, Revenue: $6.4BQ4'25, Net income: $1.2BQ4'25Q1'26, Revenue: $7.6BQ1'26, Net income: $933MQ1'26Q2'26, Revenue: $8.8BQ2'26, Net income: $1.8BQ2'26$0$3B$5B$8B$10BQ3'22, Revenue: $3.3BQ3'22, Net income: $497MQ4'22, Revenue: $3.2BQ4'22, Net income: $508MQ4'22Q1'23, Revenue: $3.0BQ1'23, Net income: $439MQ2'23, Revenue: $3.1BQ2'23, Net income: $461MQ2'23Q3'23, Revenue: $3.2BQ3'23, Net income: $514MQ4'23, Revenue: $3.3BQ4'23, Net income: $514MQ4'23Q1'24, Revenue: $3.3BQ1'24, Net income: $549MQ2'24, Revenue: $3.6BQ2'24, Net income: $525MQ2'24Q3'24, Revenue: $4.0BQ3'24, Net income: $604MQ4'24, Revenue: $4.3BQ4'24, Net income: $746MQ4'24Q1'25, Revenue: $4.8BQ1'25, Net income: $738MQ2'25, Revenue: $5.7BQ2'25, Net income: $1.1BQ2'25Q3'25, Revenue: $6.2BQ3'25, Net income: $1.2BQ4'25, Revenue: $6.4BQ4'25, Net income: $1.2BQ4'25Q1'26, Revenue: $7.6BQ1'26, Net income: $933MQ2'26, Revenue: $8.8BQ2'26, Net income: $1.8BQ2'26

Net income losses drawn in red.

Free cash flow
$0$500M$1.0B$1.5BQ3'22, Free cash flow: $455MQ3'22Q4'22, Free cash flow: $612MQ4'22Q1'23, Free cash flow: $435MQ1'23Q2'23, Free cash flow: $441MQ2'23Q3'23, Free cash flow: $543MQ3'23Q4'23, Free cash flow: $737MQ4'23Q1'24, Free cash flow: $505MQ1'24Q2'24, Free cash flow: $523MQ2'24Q3'24, Free cash flow: $474MQ3'24Q4'24, Free cash flow: $647MQ4'24Q1'25, Free cash flow: $576MQ1'25Q2'25, Free cash flow: $1.1BQ2'25Q3'25, Free cash flow: $1.2BQ3'25Q4'25, Free cash flow: $1.5BQ4'25Q1'26, Free cash flow: $830MQ1'26Q2'26, Free cash flow: $1.2BQ2'26$0$500M$1.0B$1.5BQ3'22, Free cash flow: $455MQ4'22, Free cash flow: $612MQ4'22Q1'23, Free cash flow: $435MQ2'23, Free cash flow: $441MQ2'23Q3'23, Free cash flow: $543MQ4'23, Free cash flow: $737MQ4'23Q1'24, Free cash flow: $505MQ2'24, Free cash flow: $523MQ2'24Q3'24, Free cash flow: $474MQ4'24, Free cash flow: $647MQ4'24Q1'25, Free cash flow: $576MQ2'25, Free cash flow: $1.1BQ2'25Q3'25, Free cash flow: $1.2BQ4'25, Free cash flow: $1.5BQ4'25Q1'26, Free cash flow: $830MQ2'26, Free cash flow: $1.2BQ2'26

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$5B$10B$15BQ3'22, Cash and equivalents: $1.2BQ3'22Q4'22, Cash and equivalents: $1.4BQ4'22Q1'23, Cash and equivalents: $1.4BQ1'23Q2'23, Cash and equivalents: $1.3BQ2'23Q3'23, Cash and equivalents: $1.5BQ3'23Q4'23, Cash and equivalents: $1.5BQ4'23Q1'24, Cash and equivalents: $1.9BQ1'24Q2'24, Cash and equivalents: $1.3BQ2'24Q3'24, Cash and equivalents: $1.6BQ3'24Q4'24, Cash and equivalents: $3.3BQ4'24Q1'25, Cash and equivalents: $1.7BQ1'25Q2'25, Cash and equivalents: $3.2BQ2'25Q3'25, Cash and equivalents: $3.8BQ3'25Q4'25, Cash and equivalents: $11.1BQ4'25Q1'26, Cash and equivalents: $4.1BQ1'26Q2'26, Cash and equivalents: $4.7BQ2'26$0$5B$10B$15BQ3'22, Cash and equivalents: $1.2BQ4'22, Cash and equivalents: $1.4BQ4'22Q1'23, Cash and equivalents: $1.4BQ2'23, Cash and equivalents: $1.3BQ2'23Q3'23, Cash and equivalents: $1.5BQ4'23, Cash and equivalents: $1.5BQ4'23Q1'24, Cash and equivalents: $1.9BQ2'24, Cash and equivalents: $1.3BQ2'24Q3'24, Cash and equivalents: $1.6BQ4'24, Cash and equivalents: $3.3BQ4'24Q1'25, Cash and equivalents: $1.7BQ2'25, Cash and equivalents: $3.2BQ2'25Q3'25, Cash and equivalents: $3.8BQ4'25, Cash and equivalents: $11.1BQ4'25Q1'26, Cash and equivalents: $4.1BQ2'26, Cash and equivalents: $4.7BQ2'26

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q2 FY2026 filed July 31, 2026.

Amphenol Corporation income statement, quarterly
Millions of dollarsQ2 FY2026ended Jun 30, 2026filed Jul 31, 2026Q1 FY2026ended Mar 31, 2026filed May 1, 2026Q4 FY2025ended Dec 31, 2025filed Feb 11, 2026Q3 FY2025ended Sep 30, 2025filed Oct 24, 2025Q2 FY2025ended Jun 30, 2025filed Jul 25, 2025Q1 FY2025ended Mar 31, 2025filed Apr 25, 2025Q4 FY2024ended Dec 31, 2024filed Feb 7, 2025Q3 FY2024ended Sep 30, 2024filed Oct 25, 2024YoYQ2 FY2026vs Q2 FY2025
Revenue8,7587,6206,4396,1945,6504,8114,3184,039+55.0%
Cost of revenue5,2104,8203,9783,8353,5973,1672,8372,682+44.8%
Gross profit3,5482,8002,4612,3592,0531,6441,4811,357+72.8%
Research and development—————————
Selling, general and administrative940852691657623575515492+51.0%
Operating income2,5851,8321,7231,7021,4191,025954820+82.2%
Other income (expense)1822561910152411+71.6%
Pretax income2,3881,6461,6491,6411,348963910775+77.2%
Income tax604702444386247219158166+144.4%
Net income1,7699331,1961,2461,091738746604+62.1%
Diluted EPS ($)1.370.72—0.970.860.58—0.48+59.3%
Diluted shares (millions)1,2891,290—1,2831,2721,266—1,266—

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q2 FY2026 filed July 31, 2026.

Amphenol Corporation balance sheet, quarterly
Millions of dollarsQ2 FY2026ended Jun 30, 2026filed Jul 31, 2026Q1 FY2026ended Mar 31, 2026filed May 1, 2026Q4 FY2025ended Dec 31, 2025filed Feb 11, 2026Q3 FY2025ended Sep 30, 2025filed Oct 24, 2025Q2 FY2025ended Jun 30, 2025filed Jul 25, 2025Q1 FY2025ended Mar 31, 2025filed Apr 25, 2025Q4 FY2024ended Dec 31, 2024filed Feb 7, 2025Q3 FY2024ended Sep 30, 2024filed Oct 25, 2024YoYQ2 FY2026vs Q2 FY2025
Cash and equivalents4,7294,12811,1313,7993,2071,6573,3171,563+47.5%
Short-term investments6904553048919151820+3455.2%
Total current assets17,81715,38420,26712,38411,2999,1339,6867,773+57.7%
Total assets44,80742,13436,23727,14325,66822,90221,44019,586+74.6%
Total current liabilities9,4388,9756,8035,9845,6044,5914,0843,902+68.4%
Long-term debt—————————
Total liabilities29,18528,04222,72714,53614,06912,53011,58410,059+107.4%
Stockholders’ equity15,49213,97713,41312,52011,51910,3019,7929,453+34.5%
Shares outstanding (millions)1,2331,2301,2291,2241,2211,2101,2111,206—

Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q2 FY2026 filed July 31, 2026.

Amphenol Corporation cash flow statement, quarterly
Millions of dollarsQ2 FY2026ended Jun 30, 2026filed Jul 31, 2026Q1 FY2026ended Mar 31, 2026filed May 1, 2026Q4 FY2025ended Dec 31, 2025filed Feb 11, 2026Q3 FY2025ended Sep 30, 2025filed Oct 24, 2025Q2 FY2025ended Jun 30, 2025filed Jul 25, 2025Q1 FY2025ended Mar 31, 2025filed Apr 25, 2025Q4 FY2024ended Dec 31, 2024filed Feb 7, 2025Q3 FY2024ended Sep 30, 2024filed Oct 25, 2024YoYQ2 FY2026vs Q2 FY2025
Operating cash flow1,5571,1221,7221,4711,417765847704+9.9%
Capital expenditures356292254257297189200230+19.7%
Free cash flow (CFO − capex)1,2028301,4691,2141,120576647474+7.3%
Depreciation and amortization341486249228209236144201+63.0%
Share repurchases208178171153160181169176+29.9%
Dividends paid307307202201200200199132+54.0%

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2025 filed February 11, 2026.

Income statement

Amphenol Corporation income statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 11, 2026FY2024ended Dec 31, 2024filed Feb 7, 2025FY2023ended Dec 31, 2023filed Feb 7, 2024FY2022ended Dec 31, 2022filed Feb 8, 2023FY2021ended Dec 31, 2021filed Feb 9, 2022FY2020ended Dec 31, 2020filed Feb 10, 2021FY2019ended Dec 31, 2019filed Feb 12, 2020FY2018ended Dec 31, 2018filed Feb 13, 2019FY2017ended Dec 31, 2017filed Feb 21, 2018FY2016ended Dec 31, 2016filed Feb 17, 2017FY2015ended Dec 31, 2015filed Feb 19, 2016FY2014ended Dec 31, 2014filed Feb 20, 2015FY2013ended Dec 31, 2013filed Feb 21, 2014FY2012ended Dec 31, 2012filed Feb 22, 2013FY2011ended Dec 31, 2011filed Feb 24, 2012FY2010ended Dec 31, 2010filed Feb 28, 2011FY2009ended Dec 31, 2009filed Feb 23, 2010FY2008ended Dec 31, 2008filed Aug 6, 2009FY2007ended Dec 31, 2007filed Aug 6, 2009
Revenue23,09515,22312,55512,62310,8768,5998,2258,2027,0116,2865,5695,3464,6154,2923,9403,5542,8203,2362,851
Cost of revenue14,57710,0838,4718,5957,4755,9355,6095,5474,7014,246—————————
Gross profit8,5185,1404,0844,0283,4022,6642,6162,6552,3102,0401,7801,6941,4511,3431,2441,1588871,049930
Research and development6474533423243182612342211941661251151039389786468—
Selling, general and administrative2,5461,8551,4901,4211,2261,014971960878798669645548513486458398417377
Operating income5,8693,1572,5602,5862,1051,6381,6191,6871,4281,2051,1051,035897828752700489632553
Other income (expense)10072291004931791618131084(1)0(4)
Pretax income5,6013,0122,4552,4671,9891,5271,4961,5881,3521,1411,053973847779717664447593512
Income tax1,295570509551409313332372692309281257208219188161119163148
Net income4,2702,4241,9281,9021,5911,2031,1551,205651823764709———496318419353
Diluted EPS ($)3.341.921.551.531.27*0.98*0.94*0.96*0.52*0.65*0.60*0.55*0.49*0.42*0.38*0.35*0.23*0.29*0.24*
Diluted shares (millions)1,2781,2641,2411,2421,251*1,230*1,232*1,250*1,266*1,261*1,266*1,282*1,298*1,312*1,375*1,411*1,392*1,431*1,460*

Balance sheet

Amphenol Corporation balance sheet, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 11, 2026FY2024ended Dec 31, 2024filed Feb 7, 2025FY2023ended Dec 31, 2023filed Feb 7, 2024FY2022ended Dec 31, 2022filed Feb 8, 2023FY2021ended Dec 31, 2021filed Feb 9, 2022FY2020ended Dec 31, 2020filed Feb 10, 2021FY2019ended Dec 31, 2019filed Feb 12, 2020FY2018ended Dec 31, 2018filed Feb 13, 2019FY2017ended Dec 31, 2017filed Feb 21, 2018FY2016ended Dec 31, 2016filed Feb 17, 2017FY2015ended Dec 31, 2015filed Feb 19, 2016FY2014ended Dec 31, 2014filed Feb 20, 2015FY2013ended Dec 31, 2013filed Feb 21, 2014FY2012ended Dec 31, 2012filed Feb 22, 2013FY2011ended Dec 31, 2011filed Feb 24, 2012FY2010ended Dec 31, 2010filed Feb 28, 2011FY2009ended Dec 31, 2009filed Feb 23, 2010FY2008ended Dec 31, 2008filed Aug 6, 2009FY2007ended Dec 31, 2007filed Aug 6, 2009
Cash and equivalents11,1313,3171,4751,3731,1971,7028911,2791,7191,0351,737969887691515526385215184
Short-term investments30418185614436171235139233613052521349838——
Total current assets20,2679,6866,8356,4795,9585,4914,2114,5724,6563,5913,8503,4523,1582,7072,1811,9921,4201,336—
Total assets36,23721,44016,52615,32614,67812,32710,81610,04510,0048,4997,4586,9866,1685,2154,4454,0164,0162,994—
Total current liabilities6,8034,0843,1532,6762,4472,3042,1332,4511,5791,6351,0081,0461,610889642655503635—
Long-term debt————————3,5422,6362,8132,6551,4311,6061,377800753——
Total liabilities22,72711,5848,1008,2328,2996,875—————————————
Stockholders’ equity13,4139,7928,3477,0166,3025,3854,5304,0173,9903,6753,2392,9072,8602,4302,1722,3211,7461,349—
Shares outstanding (millions)1,2291,2111,200*1,189*1,198*1,198*1,192*1,192*1,222*1,231*1,232*1,241*1,266*1,278*1,307*1,407*1,386*——

Cash flow statement

Amphenol Corporation cash flow statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 11, 2026FY2024ended Dec 31, 2024filed Feb 7, 2025FY2023ended Dec 31, 2023filed Feb 7, 2024FY2022ended Dec 31, 2022filed Feb 8, 2023FY2021ended Dec 31, 2021filed Feb 9, 2022FY2020ended Dec 31, 2020filed Feb 10, 2021FY2019ended Dec 31, 2019filed Feb 12, 2020FY2018ended Dec 31, 2018filed Feb 13, 2019FY2017ended Dec 31, 2017filed Feb 21, 2018FY2016ended Dec 31, 2016filed Feb 17, 2017FY2015ended Dec 31, 2015filed Feb 19, 2016FY2014ended Dec 31, 2014filed Feb 20, 2015FY2013ended Dec 31, 2013filed Feb 21, 2014FY2012ended Dec 31, 2012filed Feb 22, 2013FY2011ended Dec 31, 2011filed Feb 24, 2012FY2010ended Dec 31, 2010filed Feb 28, 2011FY2009ended Dec 31, 2009filed Feb 23, 2010FY2008ended Dec 31, 2008filed Aug 6, 2009FY2007ended Dec 31, 2007filed Aug 6, 2009
Operating cash flow5,3752,8152,5292,1751,5401,5921,5021,1131,1441,0781,031————425582482388
Capital expenditures99766537338436027729531122719117220915812910010963108104
Free cash flow (CFO − capex)4,3782,1492,1561,7911,1801,3151,207802918887858————315519373284
Depreciation and amortization922573406393396308312300227217172168137122119103999182
Share repurchases665689585731662641602935618326249539325380672——29494
Dividends paid80259550147734729828025420517315910297701010101111

Insider activity

Form 4 filings by officers, directors and 10% owners, November 1, 2024 to November 1, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$69M
5 sales by 3 insiders; officers and directors $69M
Bought, twelve months
$1M
1 purchases by 1 insider; officers and directors $1M
Sold, twelve months
$418M
20 sales by 7 insiders; officers and directors $418M

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Aug 6, 2026Lampo Craig AEVP& CFOgiftindirect54,547$0.00—0Aug 6, 2026
Aug 5, 2026Silverman David MEVP, Human Resourcesoption exercise120,000$22.00$3M135,672Aug 5, 2026
Aug 5, 2026Silverman David MEVP, Human Resourcesopen-market sale120,000$174.24$21M15,672Aug 5, 2026
Aug 4, 2026Lampo Craig AEVP& CFOoption exercise193,200$22.37$4M283,865Aug 5, 2026
Aug 4, 2026Lampo Craig AEVP& CFOopen-market sale193,200$167.31$32M90,665Aug 5, 2026
Aug 3, 2026D'Amico Lance EEVP, Secretary & GenCounseloption exercise50,000$22.55$1M107,065Aug 5, 2026
Aug 3, 2026D'Amico Lance EEVP, Secretary & GenCounselopen-market sale50,000$161.99$8M57,065Aug 5, 2026
Aug 3, 2026D'Amico Lance EEVP, Secretary & GenCounseloption exerciseindirect40,000$22.37$895K40,000Aug 5, 2026
Aug 3, 2026D'Amico Lance EEVP, Secretary & GenCounselopen-market saleindirect40,000$161.82$6M0Aug 5, 2026
Aug 3, 2026D'Amico Lance EEVP, Secretary & GenCounseloption exerciseindirect10,000$22.55$226K10,000Aug 5, 2026
Aug 3, 2026D'Amico Lance EEVP, Secretary & GenCounselopen-market saleindirect10,000$161.82$2M0Aug 5, 2026
Jul 31, 2026Norwitt Richard AdamPresident & CEO, Directoroption exercise500,000$22.37$11M2MAug 3, 2026
Jul 31, 2026Norwitt Richard AdamPresident & CEO, Directoropen-market sale500,000$161.57$81M2MAug 3, 2026
Jul 31, 2026Norwitt Richard AdamPresident & CEO, Directoroption exerciseindirect186,104$22.37$4M1MAug 3, 2026
Jul 31, 2026Norwitt Richard AdamPresident & CEO, Directoropen-market saleindirect186,104$162.27$30M864,177Aug 3, 2026
May 22, 2026Wolff Anne ClarkeDirectoraward1,552$0.00—1,552May 27, 2026
May 22, 2026Singh Prahlad R.Directoraward1,552$0.00—1,552May 27, 2026
May 22, 2026Livingston RobertDirectoraward1,552$0.00—1,552May 27, 2026
May 22, 2026Lane Rita S.Directoraward1,552$0.00—1,552May 27, 2026
May 22, 2026Lamba SanjivDirectoraward1,552$0.00—1,552May 27, 2026
May 22, 2026Falck David PDirectoraward1,552$0.00—1,552May 27, 2026
May 22, 2026Altobello Nancy A.Directoraward1,552$0.00—1,552May 27, 2026
May 20, 2026Lampo Craig AExecutive VP & CFOother41,203——70,907May 21, 2026
May 5, 2026Norwitt Richard AdamPresident & CEO, Directoroption exercise17,500$22.37$392K2MMay 5, 2026
May 5, 2026Norwitt Richard AdamPresident & CEO, Directoropen-market sale17,500$143.21$3M2MMay 5, 2026

Full insider history for Amphenol Corporation, or insider activity across all companies. A record of filings, not a recommendation.

Tracked funds holding it

1 of the tracked managers held APH in their latest 13F filing, through August 14, 2026. Weight is the share of the fund’s reported portfolio. How the funds have traded APH by quarter.

FundManagerQuarterValueSharesWeightMove
Baron Capital GroupRon BaronQ2 2026$282M2M0.42%trimmed −3.7%

Sources

Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
AMPHENOL CORPORATION, CIK 820313 on EDGAR
Extract generated
August 27, 2026
Withheld
none
Repaired
none
XBRL concepts behind each line

Income statement

Revenue: RevenueFromContractWithCustomerExcludingAssessedTax, SalesRevenueGoodsNet
Cost of revenue: CostOfRevenue
Gross profit: GrossProfit
Research and development: ResearchAndDevelopmentExpense
Selling, general and administrative: SellingGeneralAndAdministrativeExpense
Operating income: OperatingIncomeLoss
Other income (expense): OtherNonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: ShortTermInvestments
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: LongTermDebtNoncurrent
Total liabilities: Liabilities
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquirePropertyPlantAndEquipment
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationAndAmortization, DepreciationDepletionAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: PaymentsOfDividendsCommonStock

The data

The statements on this page as files, generated August 27, 2026.

JSON file
/data/financials/APH.json